BroadOak Logo

Latest News

Updates on BroadOak investments, transactions, events, and industry news.

Flagship Biosciences hired industry veteran Tom Turi as Chief Scientific Officer. Tom will help grow the

Following BroadOak’s growth equity investment in Flagship Biosciences, Flagship Biosciences has acquired Interpace Pharma Solutions, a

Halo Labs logo

BroadOak joined Agilent Technologies, a global leader in life sciences and diagnostics, to increase its investment

BroadOak invested in Microsize, a CDMO specializing in micronization and particle size control, as part of

BroadOak invested in Kemp Proteins, a leading CDMO specializing in the production of novel proteins. The

BroadOak Capital Partners advised Bioresource Technology (“BRT”) on the sale of the company to Medix Biochemica. 

BroadOak invested in LabVoice, a company that leverages device, software, and customized workflows to enable the

Aalto Bio Reagents Logo

BroadOak Partners advised Aalto Bio Reagents on the sale of the company to Biosynth Carbosynth, a

BroadOak Logo

BroadOak’s Q1 Quarterly Review analyzes market trends and M&A transactions across life science tools, diagnostics, and

It is an exciting time at BroadOak as we help advance innovative life sciences technologies.

Holly Atallah
Director of Finance & Operations

BroadOak Logo Only

Our Story

BroadOak has advised and invested in life sciences companies for over 15 years. Get to know us.